Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis
- PMID: 18286166
- PMCID: PMC2242778
- DOI: 10.2119/2007-00111.Maluf
Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis
Abstract
Loss of kidney graft function with tubular atrophy (TA) and interstitial fibrosis (IF) causes most kidney allograft losses. We aimed to identify the molecular pathways involved in IF/TA progression. Kidney biopsies from normal kidneys (n = 24), normal allografts (n = 6), and allografts with IF/TA (n = 17) were analyzed using high-density oligonucleotide microarray. Probe set level tests of hypotheses tests were conducted to identify genes with a significant trend in gene expression across the three groups using Jonckheere-Terpstra test for trend. Interaction networks and functional analysis were used. An unsupervised hierarchical clustering analysis showed that all the IF/TA samples were associated with high correlation. Gene ontology classified the differentially expressed genes as related to immune response, inflammation, and matrix deposition. Chemokines (CX), CX receptor (for example, CCL5 and CXCR4), interleukin, and interleukin receptor (for example, IL-8 and IL10RA) genes were overexpressed in IF/TA samples compared with normal allografts and normal kidneys. Genes involved in apoptosis (for example, CASP4 and CASP5) were importantly overexpressed in IF/TA. Genes related to angiogenesis (for example, ANGPTL3, ANGPT2, and VEGF) were downregulated in IF/TA. Genes related to matrix production-deposition were upregulated in IF/TA. A distinctive gene expression pattern was observed in IF/TA samples compared with normal allografts and normal kidneys. We were able to establish a trend in gene expression for genes involved in different pathways among the studied groups. The top-scored networks were related to immune response, inflammation, and cell-to-cell interaction, showing the importance of chronic inflammation in progressive graft deterioration.
Figures





Similar articles
-
Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.Transplantation. 2011 Mar 27;91(6):657-65. doi: 10.1097/TP.0b013e3182094a5a. Transplantation. 2011. PMID: 21242883 Free PMC article.
-
Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.Nephrology (Carlton). 2016 Jul;21 Suppl 1:26-30. doi: 10.1111/nep.12766. Nephrology (Carlton). 2016. PMID: 26972969
-
Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26. Kidney Int. 2017. PMID: 28554738
-
Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?Curr Opin Nephrol Hypertens. 2014 May;23(3):245-50. doi: 10.1097/01.mnh.0000444811.26884.2d. Curr Opin Nephrol Hypertens. 2014. PMID: 24626060 Review.
-
Molecular pathways involved in loss of graft function in kidney transplant recipients.Expert Rev Mol Diagn. 2010 Apr;10(3):269-84. doi: 10.1586/erm.10.6. Expert Rev Mol Diagn. 2010. PMID: 20370585 Free PMC article. Review.
Cited by
-
Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.Am J Transplant. 2014 May;14(5):1152-1163. doi: 10.1111/ajt.12696. Epub 2014 Apr 2. Am J Transplant. 2014. PMID: 24698514 Free PMC article. Clinical Trial.
-
Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.Transplantation. 2011 Mar 27;91(6):657-65. doi: 10.1097/TP.0b013e3182094a5a. Transplantation. 2011. PMID: 21242883 Free PMC article.
-
Downregulating ANGPTL3 by miR-144-3p promoted TGF-β1-induced renal interstitial fibrosis via activating PI3K/AKT signaling pathway.Heliyon. 2024 Jan 8;10(3):e24204. doi: 10.1016/j.heliyon.2024.e24204. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322878 Free PMC article.
-
Elucidating the nexus between onco-immunology and kidney transplantation: An insight from precision medicine perspective.Heliyon. 2024 Jun 26;10(13):e33751. doi: 10.1016/j.heliyon.2024.e33751. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040404 Free PMC article. Review.
-
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.Transplantation. 2012 Jun 15;93(11):1136-46. doi: 10.1097/TP.0b013e31824ef181. Transplantation. 2012. PMID: 22592886 Free PMC article.
References
-
- Hariharan S, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–12. - PubMed
-
- Meier-Kriesche HU, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4:378–83. - PubMed
-
- Solez K, et al. Banff ‘05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’) Am J Transplant. 2007;7:518–26. - PubMed
-
- Halloran PF, et al. Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant. 2004;11:1729–30. - PubMed
-
- Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation. 2006;81:643–54. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous